New Zealand vs United Kingdom of Great Britain and Northern Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc)
New Zealand
89.0%
in 2025
United Kingdom of Great Britain and Northern Ireland
89.0%
in 2025
New Zealand rank
72nd
United Kingdom of Great Britain and Northern Ireland rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- New Zealand
- United Kingdom of Great Britain and Northern Ireland
How they compare
New Zealand currently reports 89.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2008 it was United Kingdom of Great Britain and Northern Ireland ahead.
New Zealand ranks 72nd and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.
Across the 3 decades both report, New Zealand averaged higher in 2 and United Kingdom of Great Britain and Northern Ireland in 1.
Head to head by decade
| Decade | New Zealand | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.5% | 0.0% | 43.5% | New Zealand |
| 2010s | 92.6% | 91.7% | 0.9% | New Zealand |
| 2020s | 82.5% | 89.8% | 7.3% | United Kingdom of Great Britain and Northern Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), New Zealand or United Kingdom of Great Britain and Northern Ireland?
- New Zealand, at 89.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between New Zealand and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and United Kingdom of Great Britain and Northern Ireland?
- 18 years are reported by both, from 2008 to 2025.
- How do New Zealand and United Kingdom of Great Britain and Northern Ireland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- New Zealand ranks 72nd and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.